What is Entosystem?
Entosystem operates at the intersection of biotechnology and sustainable agriculture, utilizing cutting-edge insect farming technology to address systemic inefficiencies in the food supply chain. The company specializes in the production of entomological proteins and flours, which serve as high-quality, sustainable alternatives for animal feed and agricultural applications. By implementing a circular model, Entosystem recovers nutritional value from organic waste streams, thereby enhancing food safety and reducing the environmental footprint of traditional protein production. This market position allows the firm to capitalize on the increasing global demand for sustainable, low-carbon agricultural solutions while simultaneously addressing the urgent need for waste management innovation.
How much funding has Entosystem raised?
Entosystem has raised a total of $58M across 1 funding round:
Other Financing Round
$58M
Other Financing Round (2024): $58M with participation from Fondaction, Sanimax, and Idealist Capital
Key Investors in Entosystem
Fondaction
Fondaction is a Quebec-based investment firm focused on creating a stronger, more equitable, and greener economy by supporting local businesses and job creation.
Sanimax
Sanimax is a specialized BioReturn company that excels in rendering by-products into valuable agricultural and animal nutrition commodities.
Idealist Capital
Idealist Capital is a growth-oriented private equity firm that partners with entrepreneurs to scale sustainable solutions and reshape industries for a resilient economy.
What's next for Entosystem?
With the recent influx of capital, Entosystem is poised to accelerate its operational growth and market penetration. The strategic roadmap likely involves scaling production capacity to meet the rising demand for insect-derived proteins in the pet food and livestock sectors. Furthermore, the company is expected to refine its waste-recuperation processes, potentially expanding its footprint within the North American agricultural landscape. As the firm transitions into this next phase of development, the focus will remain on optimizing yield efficiency and strengthening its supply chain resilience. By maintaining its commitment to the circular economy, Entosystem is set to solidify its status as a leader in the sustainable protein industry, driving long-term value for stakeholders and the broader ecosystem.
See full Entosystem company page
